
Lupin Limited has informed the Exchange about press release dated 26-Aug-2022 titled Lupin Launches Desvenlafaxine Extended-Release Tablets in the United States.
Filed with NSE ·

Lupin Limited has informed the Exchange about press release dated 26-Aug-2022 titled Lupin Launches Desvenlafaxine Extended-Release Tablets in the United States.
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin